Woodcock Requests Independent Review Of Biogen-FDA Aduhelm Interaction … Not Approval Decision

 
• By Sarah Karlin-Smith
An OIG investigation would put Biogen and FDA’s relationship under a magnifying glass. • Source: Alamy

More from US FDA

More from Agency Leadership